Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ND0611 (SC Carbidopa) in Parkinson's Disease
NCT01229332Phase 2Completed
- Sponsor
- NeuroDerm Ltd.
- Start
- Jan 2011
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carbidopa in Parkinson's disease (PD), sponsored by NeuroDerm Ltd.. Started Jan 2011; status: completed.
02
Drugs
carbidopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01229332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01229332.